Inventor

LARRICK JAMES W

US42 patents

⚠️ This page may combine multiple inventors who share the name “LARRICK JAMES W”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

LARRICK JAMES W

MENLO THERAPEUTICS INC

Use of NK-1 receptor antagonist serlopitant in pruritus

Use of NK-1 receptor antagonists in pruritus

Use of NK-1 receptor antagonist serlopitant in pruritus

Use of NK-1 receptor antagonists in pruritus

Use of NK-1 receptor antagonists in pruritus

Use of NK-1 receptor antagonist serlopitant in pruritus

Use of NK-1 receptor antagonist serlopitant in pruritus

Use of NK-1 receptor antagonists in pruritus

Use of NK-1 receptor antagonists in pruritus

Use of NK-1 receptor antagonist serlopitant in pruritus

PANORAMA RES INC

Antioxidant nitroxides and nitrones as therapeutic agents

DNA-binding indole derivatives, their prodrugs and immunoconjugates as anticancer agents

Methods and compositions for detecting lipopolysaccharides using CAP18 fragments

24 kilodalton cytoplasmic protease activating DNA fragmentation in apoptosis

Mammalian cationic proteins having lipopolysaccharide binding and anti-coagulant activity

Hepatokine and methods for its use

Aminoadamantyl nitrate compounds and their use to treat CNS disorders

Assay for inhibitors of a 24 kD cytoplasmic protease which activates DNA fragmentation in apoptosis

Aminoadamantyl nitrate compounds and their use to treat CNS disorders

CETUS CORP

Pseudomonas aeruginosa exotoxin A antibodies, their preparation and use

Human lymphoblastold cell line and hybridomas derived therefrom

Human cell line and triomas, antibodies, and transformants derived therefrom

Human monoclonal antibody against group A red blood cells

Human lymphoblastoid cell line and hybridomas derived therefrom

NEUROMOLECULAR INC

Antioxidant nitroxides and nitrones as therapeutic agents

Aminoadamantane derivatives as therapeutic agents

Aminoadamantane derivatives as therapeutic agents

TIGERCAT PHARMA INC

Use of NK-1 receptor antagonists in pruritus

Use of NK-1 receptor antagonists in pruritus

Use of NK-1 receptor antagonists in pruritus

CHIRON CORP

Method for controlling hyperproliferative diseases

Multifunctional M-CSF proteins and genes encoding therefor

LARRICK JAMES W

Des-methyl-tocopherol therapy for restenosis prevention

Gamma-tocopherol therapy for restenosis prevention

PANORAMA RES

Methods and compositions for the treatment and prevention of Staphylococcal infections

CETUS ONOCOLOGY CORP

Multifunctional M-CSF proteins and genes encoding therefor

LEE RANDALL J

Compositions and methods for tissue repair

ADAMAS PHARMACEUTICALS INC

Aminoadamantane derivatives as therapeutic agents

TRUSTEES OF THE CETUS CORP BOA

Use of tumor necrosis factor as a weight regulator

VYNE THERAPEUTICS INC

Use of NK-1 receptor antagonist serlopitant in pruritus

UNIV LELAND STANFORD JUNIOR

Process for making T cell hybridomas

CTS Biopharma LLC

Anti-marinobufagenin antibodies and uses thereof